Peregrine Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Peregrine Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-341,048	Closed	-$18.4M	–	268
2017 Q4	$18.4M	Buy	341,048 +31,906	+10%	+$1.75M	0.43%	88
2017 Q3	$17.6M	Buy	309,142 +40,008	+15%	+$2.34M	0.42%	94
2017 Q2	$16.2M	Sell	269,134 -68,246	-20%	-$3.89M	0.4%	94
2017 Q1	$18M	Buy	+337,380	New	+$16.6M	0.46%	79

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Peregrine Capital Management's BIVV Position: Q1 2018 in Review

Peregrine Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 341,048 shares — an estimated $18.4M sold.

Peregrine Capital Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $18.4M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Peregrine Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Peregrine Capital Management sold 341,048 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $18.4M.
Peregrine Capital Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Peregrine Capital Management's Bioverativ Inc. Common Stock position peaked at $18.4M in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Peregrine Capital Management's 13F filing for Q1 2018, filed 16 Apr 2018.